s on BIIB's Phase 3 trials of nusinersen and the market opportunity for treatment of SMA infants and children. Host: Ying Huang Sector Specialist: Dan Lundquist Corporate Access: Caroline Goodson Time/Location: 7PM/Midtown location TBA Format: Group Dinner Bio: Yaacov Anziska, M.D, M.S. is Assistant Prof